Drawing for PRECISVIEW

USPTO serial 87818515

PRECISVIEW

Reviewed by CopyMark Law Group

Reg. 5807807Status 702Registered
Filing date
Status date
Registration date
Jul 16, 2019
Examiner
STEDMAN, CORI
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PRECISVIEW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roger H. Bora

Roger H. Bora Thompson Hine LLP10050 Innovation Drive, Suite 400Dayton, OH 45342-4934United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposesACTIVEMar 25, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 3, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 3, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 25, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jul 16, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 2, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 25, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 16, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 14, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 13, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 12, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 9, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 25, 2019IUAFUSE AMENDMENT FILED—
Mar 25, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 25, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 31, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 4, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2018CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jun 15, 2018ALIEASSIGNED TO LIE—
Jun 14, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 14, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 14, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 14, 2018DOCKASSIGNED TO EXAMINER—
Mar 10, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance